Descrizione

According to a report by StrategyHelix, the global therapeutic biologics market is set to increase by US$ 169.7 miliardi durante 2022-2028, growing at a CAGR of 7.7% durante il periodo di previsione.

Il rapporto fornisce dati aggiornati sulle dimensioni del mercato per il periodo 2018-2021 e previsione a 2028 covering key market aspects like sales value for therapeutic biologics. The global therapeutic biologics market is segmented on the basis of product, e regione. In base al prodotto, the global therapeutic biologics market has been segmented into therapeutic proteins, vaccines, altri. Tra questi, the therapeutic proteins segment was accounted for the highest revenue generator in 2021. Geograficamente, the global therapeutic biologics market is segmented into Asia Pacific, Europa, Nord America, COSA (Medio Oriente e Africa), America Latina. North America is estimated to account for the largest share of the global therapeutic biologics market.

The global therapeutic biologics market is highly competitive. Key companies profiled in the report include Amgen Inc., Baxter International Inc., China Biologic Products Holdings Inc., CSL Ltd., Eli Lilly and Company, GlaxoSmithKline plc (GSK plc), Grifols S.A., Kedrion S.p.A., Novartis AG, Octapharma AG, Reliance Life Sciences, Roche Holding AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd.

Il rapporto è una risorsa inestimabile per le aziende e le organizzazioni attive in questo settore. It provides a cohesive picture of the therapeutic biologics market to help drive informed decision making for industry executives, decisori politici, accademico, e analisti.

Ambito del rapporto

Prodotto: therapeutic proteins, vaccines, altri
Regione: Asia Pacifico, Europa, Nord America, COSA (Medio Oriente e Africa), America Latina
Anni considerati: la presente relazione copre il periodo 2018 A 2028

Principali vantaggi per gli stakeholder

– Get a comprehensive picture of the global therapeutic biologics market
– Individuare i settori in crescita e le tendenze per gli investimenti

Sommario

Parte 1. introduzione
– Ambito dello studio
– Periodo di studio
– Ambito geografico
– Metodologia di ricerca
Parte 2. Therapeutic biologics market overview
Parte 3. Ripartizione del mercato per prodotto
– Therapeutic proteins
– Vaccines
– Altri
Parte 4. Market breakdown by region
– Asia Pacifico
– Europa
– Nord America
– COSA (Medio Oriente e Africa)
– America Latina
Parte 5. Aziende chiave
– Amgen Inc.
– Baxter International Inc.
– China Biologic Products Holdings, Inc.
– CSL Ltd.
– Eli Lilly and Company
– GlaxoSmithKline plc (GSK plc)
– Grifols, SA.
– Kedrion S.p.A.
– Novartis AG
– Octapharma AG
– Reliance Life Sciences
– Roche Holding AG
– Sanofi S.A.
– Teva Pharmaceutical Industries Ltd.
Informazioni su StrategyHelix
Disclaimer